Using qRT-PCR, we found that methylation of the PLA2R1 promoter was significantly elevated (fold change = 1.079, p < 0.0001) in breast cancer tissues when compared with the benign control (Figure 3B). Here, PLA2R1 is linked to breast carcinoma.